Ozempic Rivals: Anvisa Ruling Soon on Wegovy & Mounjaro
Brazil’s Obesity Treatment Landscape: Wegovy’s Arrival Signals a New Era of Competition and Access Over 20% of adults in Brazil are now classified as obese, a figure that’s rapidly climbing alongside rising rates of type 2 diabetes and cardiovascular disease. This escalating health crisis is poised for a significant shift as Novo Nordisk submits Wegovy, … Read more